LRRK2 and Parkinson disease: Nonetheless, these data could collectively outline a pathway from overactivated pathogenic LRRK2 to irregular inactivation of Rab5 and endosomal deficits, and although further confirmation is needed, Rab5 may be one of the key players behind PD development and progression.